Back to search
FDAFDA · Food and drugs·Recall number D-0847-2026

Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30.

Published September 9, 2026 · Recall initiated: August 21, 2026

Summary

FDA records drug Class II recall D-0847-2026, published September 9, 2026 and initiated August 21, 2026. Recalling firm: Golden State Medical Supply Inc.; Status: Ongoing; Reported quantity: 6791 30-count bottles; Lot: Lot # GS062298, Exp Date: 09/30/ 2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution

What to do

Voluntary: Firm initiated · Letter

Get an email if PRASUGREL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PRASUGREL
Manufacturer
Golden State Medical Supply Inc.
Distributor
US Nationwide.
Lot
Lot # GS062298, Exp Date: 09/30/ 2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30. recalled?

Yes. FDA published recall D-0847-2026 on September 9, 2026. Reported hazard: Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PRASUGREL.